M
Manitoba Allergy Research Inc. | Winnipeg, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tapinarof
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...
Enrolling
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%
The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut a...
Enrolling
Peanut Allergy
Allergy
Combination Product: DBV712 250 mcg
Combination Product: Placebo
Trial sponsors
D
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems